2006 Volume 24 Pages 109-113
Objective : The purpose of this study was to evaluate the efficacy and safety of radiofrequency ablation (RNA) in patients with hepatic metastases.
Materials and Methods : Fourteen patients with a total of 21 hepatic metastases (1.0-5.0 cm in diameter) were treated with RFA.
Results : There were no treatment-related deaths. Twenty of 21 treated tumor were completely necrotic on imaging studies. With a median follow-up of 31.4 months, tumor has recurred in 5 of these 20 treated lesions (25%). One of these tumors (2.0 cm in diameter) was located near the right hepatic vein, and other four were more than 3.5 cm in diameter.
Conclusion : RFA is a safe and effective treatment to treat hepatic metastases.